Metronomic radiological surveillance in clinically stable MS patients on anti CD20 immunotherapy is redundant

Mult Scler Relat Disord. 2024 May:85:105541. doi: 10.1016/j.msard.2024.105541. Epub 2024 Mar 6.

Author

Jagannadha Avasarala¹

Affiliation

¹ Department of Neurology, University of Kentucky Medical Center, Lexington, KY 40536, USA. Electronic address: [email protected].

PMID: 38457884
DOI: 10.1016/j.msard.2024.105541

No abstract available

Publication types

Letter

MeSH terms

Adult
Antigens, CD20 / immunology
Female
Humans
Immunologic Factors* / administration & dosage
Immunotherapy / methods
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis / diagnostic imaging
Multiple Sclerosis / drug therapy
Multiple Sclerosis / immunology
Multiple Sclerosis / therapy
Multiple Sclerosis, Relapsing-Remitting / diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Multiple Sclerosis, Relapsing-Remitting / immunology
Rituximab / administration & dosage

Substances

Immunologic Factors
Rituximab
Antigens, CD20